- Home
- ALRN vs PMVP Comparison
ALRN vs PMVP Comparison
Compare ALRN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- PMVP
- Stock Information
- Founded
- ALRN 2001
- PMVP 2013
- Country
- ALRN United States
- PMVP United States
- Employees
- ALRN N/A
- PMVP N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ALRN Health Care
- PMVP Health Care
- Exchange
- ALRN Nasdaq
- PMVP Nasdaq
- Market Cap
- ALRN 76.9M
- PMVP 85.5M
- IPO Year
- ALRN 2017
- PMVP 2020
- Fundamental
- Price
- ALRN $3.42
- PMVP $1.63
- Analyst Decision
- ALRN Strong Buy
- PMVP Strong Buy
- Analyst Count
- ALRN 1
- PMVP 4
- Target Price
- ALRN $19.00
- PMVP $5.75
- AVG Volume (30 Days)
- ALRN 93.8K
- PMVP 199.3K
- Earning Date
- ALRN 11-26-2024
- PMVP 11-07-2024
- Dividend Yield
- ALRN N/A
- PMVP N/A
- EPS Growth
- ALRN N/A
- PMVP N/A
- EPS
- ALRN N/A
- PMVP N/A
- Revenue
- ALRN N/A
- PMVP N/A
- Revenue This Year
- ALRN N/A
- PMVP N/A
- Revenue Next Year
- ALRN N/A
- PMVP N/A
- P/E Ratio
- ALRN N/A
- PMVP N/A
- Revenue Growth
- ALRN N/A
- PMVP N/A
- 52 Week Low
- ALRN $1.57
- PMVP $1.40
- 52 Week High
- ALRN $7.42
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- ALRN 47.41
- PMVP 53.07
- Support Level
- ALRN $3.37
- PMVP $1.63
- Resistance Level
- ALRN $3.92
- PMVP $1.82
- Average True Range (ATR)
- ALRN 0.35
- PMVP 0.06
- MACD
- ALRN -0.06
- PMVP -0.00
- Stochastic Oscillator
- ALRN 21.36
- PMVP 30.43
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.